日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Proposal for new European pharmaceutical legislation to permit access to custom-made anti-sense oligonucleotide medicinal products

关于允许获取定制反义寡核苷酸药物的欧洲新药品立法提案

Johnston, John D; Feldschreiber, Peter

Challenges posed to the European pharmaceutical regulatory system by highly personalized medicines

高度个性化药物对欧洲药品监管体系带来的挑战

Johnston, John D; Feldschreiber, Peter

Medicolegal neglect? The case for physical activity promotion and exercise medicine

医疗法律上的疏忽?促进体育活动和运动医学的必要性

Weiler, Richard; Feldschreiber, Peter; Stamatakis, Emmanuel

The European Medicines Agency review of eltrombopag (Revolade) for the treatment of adult chronic immune (idiopathic) thrombocytopenic purpura: summary of the scientific assessment of the Committee for Medicinal Products for Human Use

欧洲药品管理局对艾曲波帕(Revolade)治疗成人慢性免疫性(特发性)血小板减少性紫癜的审查:人用药品委员会科学评估摘要

Nieto, Maria; Calvo, Gonzalo; Hudson, Ian; Feldschreiber, Peter; Brown, David; Lee, Ching Cheng; Lay, Geoffrey; Valeri, Anna; Abadie, Eric; Thomas, Angela; Pignatti, Francesco

Public health issues with counterfeit medicines

假药引发的公共卫生问题

Feldschreiber, Peter